Skip to content
PaperFren

Research method

16S rRNA Amplicon Sequencing

16S rRNA amplicon sequencing PCR-amplifies a variable region of the bacterial ribosomal RNA gene from a mixed sample, then clusters or denoises the reads into taxa (OTUs or ASVs). It estimates who is present and at what relative abundance, not a genome, not a fungus (unless a second marker such as ITS is added), and not an absolute cell count unless a separate quantification step is included. Because counts are compositional, a rise in one taxon’s relative abundance can be a fall in others rather than growth of that taxon.

Microbiome papers reach for 16S when they need a community snapshot of a body site, a hive, or a stool time series. It answers 'how does this habitat or treatment shift the bacterial profile?' Its main limitation is that composition is not causality: a taxon that blooms before disease, or after a pesticide, has not been shown to cause the outcome, and depth and primer choice set which taxa can even be seen.

Studies

6

Findings

4

6 supporting · 0 challenging · 0 qualifying citations

Open tensions

2

Currently

What we know

  1. Body habitat dominates taxonomy in healthy humans. Analysis of more than 24 million 16S reads from 2,983 specimens detected 30 phyla to 929 genera; habitats differed strongly, with average V3–V5 depth around 8,167 reads. The map is biogeography, not a disease mechanism.
  2. Experimental perturbations shift 16S profiles and, in bees, survival. In-hive pesticides altered hundreds of bacterial OTUs and ITS fungi in foragers and brood; tetracycline dropped four of eight core bee-gut species and raised mortality, a spike not seen in germ-free bees given the same antibiotic.
  3. Longitudinal human 16S can put a taxon on a timeline without proving it causes disease. In 947 stools from 76 HLA-risk children, Bacteroides dorei dominated before persistent autoantibodies (mean diagnosis age 16.8 months) in seroconverters versus controls — an observational sequence, not a demonstration that B. dorei causes type 1 diabetes.
  4. 16S-style community profiles are sometimes paired with metabolites or, in infants, with shotgun metagenomes and host transcripts. A METSIM subset linked gut microbes to plasma metabolites and metabolic traits in Finnish men; six breast-fed versus six formula-fed infants showed diet-altered Firmicutes/Actinobacteria and many differentially expressed host immunity genes.

Largest unresolved question

Observational blooming and experimental knockdown are not the same evidence. B. dorei rises before autoimmunity in a birth cohort; bee antibiotics and pesticides are assigned exposures with community and (for tetracycline) survival readouts. The first cannot support 'kill this taxon to prevent T1D'; the second still does not prove that every OTU shift causes colony collapse.

Procedure

How it works

The main stages of the method. Specific protocols and analysis choices vary between studies.

  1. Extract DNA from a mixed sample

    Community DNA is purified from a body site, hive, or stool time series. Which cells entered the tube, and at what depth, bound which taxa can later be seen.

  2. Amplify a 16S variable region

    PCR of one ribosomal marker (often V3–V5) is the filter. Functional genes, most fungi, and strain-level variants stay out unless a second marker such as ITS or a metagenome is added.

  3. Sequence, then cluster or denoise

    Reads become OTUs or ASVs. Primer choice and clustering decide the taxonomic grain; a genus table is not a genome.

  4. Estimate relative abundance

    The output is who is present and at what share of the amplicon pool. Counts are compositional: a rise in one taxon's relative abundance can be a fall in others rather than growth of that taxon.

  5. Do not treat composition as a genome or a cause

    16S answers how this habitat or treatment shifts the bacterial profile. A taxon that blooms before disease has not been shown to cause it, and an antibiotic mortality effect can still be the disrupted microbiota rather than direct drug toxicity.

Common misconceptions

  • 16S sequencing tells you the complete microbial genome content of a sample.

    It sequences one gene marker. Functional genes, strain-level variants and most non-bacteria are out of scope unless another assay is added, as when the infant paper uses stool metagenomes or the bee pesticide paper adds ITS for fungi.

  • If a bacterium is more abundant before a disease, it caused the disease.

    B. dorei dominance precedes autoantibodies in an HLA-risk cohort; the authors do not claim it causes type 1 diabetes. Compositional 16S also cannot by itself prove a taxon grew rather than that others shrank.

  • An antibiotic mortality effect in bees must be direct drug toxicity.

    Tetracycline killed core gut species and raised mortality in conventionally colonised workers; germ-free bees did not show the same mortality spike, which implicates the disrupted microbiota rather than a universal toxic dose.

Related